A four-day rebound in biotechnology stocks may be about to gain momentum after an industry ETF rose above a key resistance level, according to at Miller Tabak's Matt Maley https://t.co/Sa0UHiVwr6— Bloomberg (@business) March 18, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


